|
|
CENTER FOR DRUG EVALUATION AND RESEARCH
DIVISION of
DRUG INFORMATION
Your source for the latest drug information. Know the moment it happens.
|
|
“Q&A with FDA” Podcast Series
Conversation on Paxlovid and COVID-19
FDA/CDER’s Division of Information (DDI) has launched a new monthly podcast series, “Q&A with FDA” providing engaging conversation and discussion surrounding trending regulatory topics. DDI responds to thousands of inquiries from the public every month. In this new podcast series, we will be answering some of our most commonly received questions. Perhaps you have had the same questions but never asked.
The first episode kicks off with a conversation with Dr. Farley, Director of CDER’s Office of Infectious Diseases, discussing Paxlovid, an oral treatment in the management non-hospitalized adults with COVID-19.
|
|
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. |
|
|
|
